-
, coronaviruses, influenza, pneumonia, RSV) as well as pollution, tobacco, pollen, weather, drugs, foods and stinging insects. The long-term plan for the Driver Programme is to extend the data science capabilities
-
Drug-resistant fungal infections—caused by species like Candida auris, Cryptococcus neoformans, and Aspergillus fumigatus—pose a growing threat in healthcare, with mortality rates exceeding 50% in
-
. The within-host model will be linked to: a clinical trial simulation, an essential tool in drug development, to inform the clinical trial design of novel treatments, an individual-based transmission model
-
, showing potential to treat various cancers. The aim of this project is to use a multidisciplinary approach involving (bio)chemistry, computer aided drug design, cell biology and genetics to develop more
-
supported by the Cell-Scale Biomechanics Lab , and is part of the lab’s recent technology-development projects, aimed at improving the accuracy of drug efficacy screening for chemotherapy. A recent press
-
of new targeted cancer treament, the ICT-DTC was established in 2018 following a major £2m investment by ICT spin-out company Incanthera plc. Project Background Antibody-drug conjugates (ADCs) have emerged
-
Supervisors: Prof. Reinhard Maurer, Prof. Scott Habershon In drug discovery, millions of molecules need to be screened for their viability as drug candidate, including their synthetic viability
-
Do you want to design and construct synthetic life-like cells? A major goal of synthetic biology is to create life-like artificial cells from non-living components, i.e. the bottom-up approach